Improving neighborhood environments to reduce cancer risk in low-income areas
Research Project 1
This study is looking at how making neighborhoods safer and more supportive can help lower the risk of cancer, especially in areas with ongoing poverty, and it’s designed for people living in those communities.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-11082242 on NIH RePORTER |
What this research studies
This research investigates how changes to neighborhood environments can impact cancer prevention and outcomes, particularly in areas with persistent poverty. It focuses on enhancing both the built environment, such as walkability and safety, and the social environment, including community support and access to healthcare. By implementing a comprehensive community intervention called Cancer PREEMpT, the project aims to assess whether these improvements can lead to reduced cancer risk. The study will involve community engagement and evaluation over a five-year period.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals residing in areas of persistent poverty who are at risk for cancer due to their neighborhood conditions.
Not a fit: Patients living in affluent neighborhoods or those not affected by social determinants of health related to cancer risk may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to significant reductions in cancer risk for individuals living in disadvantaged neighborhoods.
How similar studies have performed: Other research has shown that community interventions targeting social determinants of health can lead to improved health outcomes, suggesting potential success for this approach.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Bateman, Lori Brand — University of Alabama at Birmingham
- Study coordinator: Bateman, Lori Brand
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.